Samsara Therapeutics expands into new R&D lab space at the Wood Centre for Innovation
Biotech start-up Samsara Therapeutics, an early-stage drug discovery company, has expanded into a further 1,000 sq ft of R&D lab space
DJS acquired by AbbVie & other autumn highlights from our innovation centres
Nothing stands still in the innovation space! This autumn has been an exciting time for growth and development for companies in our Wood Centre for Innovation and Oxford Centre for Innovation. We’ve gathered some of the latest highlights to share the successes of these companies along their innovation journey.
Five minutes with Natalie Jackson, Marketing & Commercial Manager at RedShiftBio
Lawrie IP is a Glasgow-based firm of patent and trademark attorneys that has recently extended its operations south to Oxford. The company helps clients protect new technologies and brands.
Five minutes with Jim Roberston, Chartered Patent Attorney at Lawrie IP
Lawrie IP is a Glasgow-based firm of patent and trademark attorneys that has recently extended its operations south to Oxford. The company helps clients protect new technologies and brands.
Five minutes with Peter Gardom, Director of This Great Adventure
“This Great Adventure” is a well-known song but the company of the same name has made a business out of technology-based story-telling.
Five minutes with Simon Jones, CEO of Helio Display Materials
Helio Display Materials moved into the Wood Centre for Innovation in April with a mission to revolutionise television screen performance with its new technology that makes colours more vivid while reducing power consumption.
Five minutes with Rhys Newman, Co-Founder & CSO of Visionary Machines
We spoke to Dr Rhys Newman, Co-Founder and Chief Scientific Officer, about Visionary Machines and the software they are developing to create superhuman vision for machines.
Five minutes with Alex Batchelor, Co-founder & CEO at OxDX
OxDX Ltd has moved into R&D labs at the Trust’s Wood Centre for Innovation to commercialise a novel approach of detecting pathogens by the unique light signature they emit when made fluorescent.
Five minutes with James Peach, Co-founder & CEO at Human Centric Drug Discovery
Starting with migraines, Human Centric Drug Discovery is relying on human data to find a new generation of drugs to treat brain disorders.
Five minutes with Professor Andrew Briggs, Co-Founder of QuantrolOx
We spoke to Executive Chair and Co-Founder of QuantrolOx, Professor Andrew Briggs to find out about the company’s pioneering quantum technology.
